Find out more about the ERA4TB project by downloading our information leaflet:

@IHIEurope @AMR_Combine.

This week at @GordonConf , Santiago Ramon (@unizar) presented his poster on how #ERA4TB has built a multi-institutional and multidisciplinary network of more than 150 highly qualified and perfectly coordinated scientists to advance new TB drugs #TBpipeline #TranslationalResearch

Ainhoa (@Ainhoa_LQ) presented @GordonConf today, on behalf of #ERA4TB consortium. She showcased the important role that ERA4TB's #InVitroModels play in our translational framework to advance TB drug candidates through the pipeline. Contact Ainhoa to find out more #DrugDevelopment

@GordonConf @uc3m @AMRAccelerator These tools are highly standardized across ERA4TB partners, ensuring the generation of robust, comparable data to support the progression of promising drug candidates. 2/2.

@GordonConf @uc3m @AMRAccelerator His work highlights how viability assays and molecular biomarkers are used as complementary tools to inform and strengthen the translational framework within ERA4TB. 1/2.

@GordonConf Juan Calvet (@uc3m) presented a poster on the integration of molecular biomarkers into time-kill assays for evaluating new anti-TB drug candidates. @AMRAccelerator . #Tuberculosis #TB #TranslationalResearch #Biomarkers #TimeKillAssays

We're at the @GordonConf on Tuberculosis Drug Discovery and Development. Come talk to us! . #ERA4TB #TB #TranslationalResearch #DrugDevelopment.

Diana Aguilar presented at #ASMMicrobe on June 22, on behalf of the ERA4TB consortium. Her talk shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens. #TuberculosisResearch #DrugDevelopment

Lara Visuna from ERA4TB partner @uc3m is attending the 38th IEEE International Symposium on Computer-Based Medical Systems, held in Madrid. Lara was presenting on ‘Detection of active and latent tuberculosis with explainable deep learning ensembles’ along with her colleagues. #TB

RT @CNRIAC: There are two positions available at @CNRsocial_ #cnr_iac for researchers on the @IMI_ERA4TB project on a fixed-term basis. Se….

Wishing good luck to the ERA4TB consortium members presenting at @page_meeting this week. #TBResearch #TB #Tuberculosis

Some highlights from our incredible ERA4TB 9th Consortium Meeting last week in Zaragoza!. 🔬Keynotes on antimicrobial resistance & new TB medicine development .💊Progress on TBAJ-587 advancing to phase 2 readiness .🔍Novel drug testing approaches & mechanisms of action

🗓️3rd June 2025. ERA4TB Researcher Lindsay Sonnenkalb from.@FZBorstel , is taking part in the ‘Book a Scientist’ Event, where you can book a slot with an expert from the Leibniz Association for 25 minutes. ➡️Book here:

Some photos of Eik Hoffmann from ERA4TB partner @PasteurLille (IPL) at the #EMBOcellBioHostPath conference in Blois (France) presenting the ERA4TB host-pathogen interaction platform (BT08) and enjoying vivid discussions with TB experts in the field.

And the ERA4TB 9th Consortium Meeting is over!. Thanks to our host @unizar, all our partners, our key-note speakers and the Scientific Advisory Board members for their attendance and insightful contributions.

Reflecting on Day 2 the ERA4TB Meeting 💡. "So what next, how do you take this outstanding drug discovery programme and make sure it is handed over to drug delivery and has the impact it deserves?". Dr Francesca Conradie & Dr Gilla Kaplan, ERA4TB Scientific Advisory Board

Carlos Martín from @unizar is now taking to the stage to present: “MTBVAC: A TB vaccine candidate in the process of clinical validation”. Watch online now! #Tuberculosis #TBvaccines #MTBVAC

Starting day 2 of the ERA4TB annual meeting with Ann Ginsburg from @gatesfoundation speaking about the TB vaccine clinical pipeline. Watch online now!. #Tuberculosis #TBvaccines. @ServInvestUC3M @institutpasteur @GSK_ES @IHIEurope @AMRAccelerator

ERA4TB 9th Consortium Meeting - Day 1 ✅. Thank you to all our speakers for their great work!. Looking forward to Day 2. #Tuberculosis #TBVaccines #ERA4TB

David Barros, @GSK_ES, Santi Ramon @s_ramongarcia and Ainhoa Lucia from @unizar take to the stage now to open our next session on the progress of the assets within the ERA4TB pipeline.